Literature DB >> 4945790

Rifampicin, a general review.

G Binda, E Domenichini, A Gottardi, B Orlandi, E Ortelli, B Pacini, G Fowst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4945790

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  32 in total

Review 1.  The emergence of antibiotic resistance: myths and facts in clinical practice.

Authors:  J M Hamilton-Miller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Effect of rifampin on nasal carriage of Staphylococcus aureus.

Authors:  M A Sande; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

4.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

5.  Genetic analysis of Staphylococcus aureus RNA polymerase mutants.

Authors:  T O Morrow; S A Harmon
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

6.  A physiologically based pharmacokinetic model of rifampin in mice.

Authors:  Michael A Lyons; Brad Reisfeld; Raymond S H Yang; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

7.  Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials.

Authors:  R Bayston; N Grove; J Siegel; D Lawellin; S Barsham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

8.  Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.

Authors:  Catherine Clark; Lois M Ednie; Gengrong Lin; Kathy Smith; Klaudia Kosowska-Shick; Pamela McGhee; Bonifacio Dewasse; Linda Beachel; Patrick Caspers; Bérangère Gaucher; Gürkan Mert; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

9.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

Review 10.  Clinical pharmacokinetics of rifampicin.

Authors:  G Acocella
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.